Pierre Fabre Medicament
Pierre Fabre Group is a private, French multinational, pharmaceutical and dermo-cosmetic company present in 130 countries, and 86%-owned by a government-recognized public-interest foundation. Oncology is one of our priorities, with programs focusing particularly on targeted therapies, biotherapies and immuno-oncology. We work in therapeutic areas of high unmet medical need, including hemato-oncology and dermato-oncology. Thanks to our experience in both innovation and manufacturing, we are recognized as one of the leading global names in oncology.
http://www.pierre-fabre.com